Tegafur‐uracil‐induced pericardial effusion during adjuvant chemotherapy for resected lung adenocarcinoma: A case report

Tegafur‐uracil‐induced pericardial effusion during adjuvant chemotherapy for resected lung adenocarcinoma: A case report

Abstract In Japan, oral administration of tegafur‐uracil is recommended as postoperative adjuvant chemotherapy for patients diagnosed with primary lung adenocarcinomas of >2 cm size and staged as IA, IB, and IIA. Reports on chemotherapy‐induced pericardial effusion are rare. Herein, we report a r...

Full description

Bibliographic Details
Main Authors: Nobutaka Kawamoto, Riki Okita, Masataro Hayashi, Masanori Okada, Hidetoshi Inokawa
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Thoracic Cancer
Subjects:
adjuvant chemotherapy
adverse event
lung cancer
pericardial effusion
tegafur‐uracil
Online Access:https://doi.org/10.1111/1759-7714.13840

Similar Items

Similar Items